drugset

drugset / Trial / NCT00378495

Miltefosine for Brazilian Visceral Leishmaniasis

NCT00378495 ↗

Phase 1/2 Terminated 80 enrolled AB Foundation AEterna Zentaris · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Miltefosine will be administered to Brazilian patients with kala azar

Timeline

Start: 2005-04
Primary completion: 2007-04
Completion: 2007-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Miltefosine	Small molecule	2.5 mg/kg	—

Indications